Stock screenerAll disclosures →
EDGAR →
SANA
Conviction 39HealthcareScan · Thu, Jun 25, 2026SANA$3.27-0.30%
ResistanceSupportVol 14Vol MA14 4.11M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price3.27
Change-0.30%
Gap+2.59%
Rel volume1.37×
Avg volume4.11M
Avg $ vol12.48M
SMA 203.03
SMA 503.21
SMA 2003.84
Price vs 50+1.77%
Price vs 200-14.87%
MA stackmixed
50/200 cross—
Supertrendup · 2.71
RSI (14)57
MACD hist0.07
MACD crossbull · 5d
Stoch %K / %D73 / 77
ADX (14)18
+DI / −DI24 / 15
RSI divergence—
MACD divergence—
ATR %+6.92%
ADR %7.25%
52w high5.92
52w low2.68
From 52w high-44.76%
Above 52w low+22.01%
New 52w highNo
SqueezeOff
Bollinger width31.08%
%B0.76
Donchian pos72.93%
Donchian high3.52
Donchian low2.61
AVWAP (52w high)4.05
vs AVWAP high-19.17%
AVWAP (52w low)3.90
vs AVWAP low-16.19%
OBV trendUp
Chaikin MF (20)-0.05
Today vs 20d1.37×
Avg vol (14d)4.11M
Avg vol (20d)4.11M
Avg $ vol (20d)12.48M
Market cap910.01M
RS 3m (vs SPY)+0.07%
RS 6m (vs SPY)-32.51%
RS line new highNo
Trend template2/8
Technical rank37.3
1 week+7.57%
1 month+7.21%
3 months+5.48%
6 months-28.45%
1 year+10.10%
YTD-21.96%
P/E-3.73
P/B7.63
P/S—
P/FCF-6.29
EPS-0.9600
Div yield—
ROE-204.77%
ROA-65.36%
Debt/Eq—
Current1.29
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth8.47%
Price target9.80
Target upside199.69%
Analyst ratingBuy
Institutional61.90%
Ent. value826.21M
Revenue—
Net income-47.21M
Gross profit—
Free cash flow-144.77M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out278.29M
Employees142
ListedThu, Feb 4, 2021
Free float157.95M
Float %58.5%
Short interest39.33M
Days to cover10.4d
Short volume53.2%
Squeeze score79 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.14 vs −$0.15
Last surprise+6.7% beat
Setup gradeD
Conviction39 / 100
Pattern quality—
Tech rank37.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.73
Support2.64
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SANA
No recent disclosed trades by Congress in SANA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SANA · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
REICIN ALISE Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
Rosiello Robert L. Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
Bilenker Joshua H. Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
Mulligan Richard Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
Bishop Hans Edgar Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
NELSEN ROBERT Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
Seitz Michelle Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
Yang Patrick Y Director · Stock Option (Right to Buy) · 2026-06-04 | Grant | 90K | $0 | 2026-06-04 | 2026-06-05 |
SEC filings
EDGAR filings in SANA · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.